AntioncoRAN-M

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAntioncoRAN-M
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionCytokines modulators
TargetsCytokines
Therapy Area/IndicationsMetastatic breast cancerVulvar Intraepithelial NeoplasiaSolid tumours +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRussian Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesGene Surgery LLC
Inactive CompaniesRussian Academy Of Sciences
Active IndicationsMetastatic breast cancerVulvar Intraepithelial NeoplasiaSolid tumours +[10] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A